Dashputre Ankur A, Potukuchi Praveen K, Sumida Keiichi, Kar Suryatapa, Obi Yoshitsugu, Thomas Fridtjof, Molnar Miklos Z, Streja Elani, Kalantar-Zadeh Kamyar, Kovesdy Csaba P
Institute for Health Outcomes and Policy, College of Graduate Health Sciences, University of Tennessee Health Science Center, Memphis, TN, USA.
Division of Nephrology, Department of Medicine, University of Tennessee Health Science Center, Memphis, TN, USA.
Kidney Int Rep. 2021 Jan 14;6(2):366-380. doi: 10.1016/j.ekir.2020.11.022. eCollection 2021 Feb.
Patients with advanced non-dialysis-dependent chronic kidney disease (NDD-CKD) are prone to potassium (K) imbalances due to reduced kidney function. Both hypo- and hyperkalemia are associated with increased mortality; however, it is unclear if K variability before dialysis initiation is associated with outcomes after dialysis initiation.
We identified 34,167 US veterans with advanced NDD-CKD transitioning to dialysis between October 1, 2007, through March 31, 2015, who had at least 1 K measurement each year over a 3-year period before transition (3-year prelude). For each patient, a linear mixed-effects model was used to regress K over time (in years) over the 3-year prelude to derive K variability (square root of the average squared distance between the observed and estimated K). The main outcomes of interest were 6-month all-cause and cardiovascular mortality after dialysis initiation. Multivariable Cox and Fine-Gray competing risk regression adjusted for 3-year prelude K intercept, K slope (per year), demographics, smoking status, comorbidities, length of hospitalizations, body mass index, vascular access type, medications, average estimated glomerular filtration rate, and number of K measurements over the 3-year prelude were used to assess the association of K variability (expressed as quartiles) with all-cause and cardiovascular mortality, respectively.
Higher prelude K variability was associated with higher multivariable-adjusted risk of all-cause mortality but not cardiovascular mortality (adjusted hazard/subhazard ratios [95% confidence interval] for highest quartile [vs. lowest] of K variability, 1.14 [1.03-1.25] and 0.99 [0.85-1.16] for all-cause and cardiovascular mortality, respectively).
Higher K variability is associated with higher all-cause mortality after dialysis initiation.
晚期非透析依赖型慢性肾脏病(NDD-CKD)患者由于肾功能下降,容易出现钾(K)失衡。低钾血症和高钾血症均与死亡率增加相关;然而,透析开始前的血钾变异性是否与透析开始后的预后相关尚不清楚。
我们确定了34167名美国退伍军人,他们在2007年10月1日至2015年3月31日期间从晚期NDD-CKD过渡到透析,在过渡前的3年期间(3年前期)每年至少进行1次血钾测量。对于每位患者,使用线性混合效应模型对3年前期随时间(以年为单位)的血钾进行回归,以得出血钾变异性(观察到的血钾与估计血钾之间平均平方距离的平方根)。主要关注的结局是透析开始后的6个月全因死亡率和心血管死亡率。使用多变量Cox和Fine-Gray竞争风险回归,对3年前期血钾截距、血钾斜率(每年)、人口统计学特征、吸烟状况、合并症、住院时间、体重指数、血管通路类型、药物治疗、平均估计肾小球滤过率以及3年前期的血钾测量次数进行调整,分别评估血钾变异性(以四分位数表示)与全因死亡率和心血管死亡率之间的关联。
较高的前期血钾变异性与多变量调整后的全因死亡风险较高相关,但与心血管死亡风险无关(血钾变异性最高四分位数[与最低四分位数相比]的调整后风险比/亚风险比[95%置信区间],全因死亡率为1.14[1.03-1.25],心血管死亡率为0.99[0.85-1.16])。
较高的血钾变异性与透析开始后的全因死亡率较高相关。